mTOR-S6k is one of the most common deregulated pathways in various cancers, and overactivation of the mTOR pathway is closely related to cell growth, metabolism, aging, insulin resistance and obesity, of which are the most common risk factors resulting in MetS [15, 16]. The gene discussed is RPS6KB1; the disease is metabolic syndrome.